In non-small-cell lung cancer (NSCLC), it inhibits the growth and metastasis of NSCLC by blocking the PI3K/Akt signaling pathway by targeting MALAT-1 [11]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.